Roundup: Five China Regulatory Must-Reads From 2014
This article was originally published in PharmAsia News
Executive Summary
Change, turmoil and transition mark the passing Year of the Horse for the China pharma industry. If you have missed some of the highlights, here is your opportunity to check out the top China drug regulatory happenings in 2014.